CyberKnife Treatment for International Patients in India

Why Do International Patients Choose India for CyberKnife?

Patients travel for stereotactic radiation for practical reasons, and the strongest ones are about reaching an experienced team and a well-planned treatment at a price that does not force a compromise on quality:

• Significantly lower cost. Private Indian hospitals often quote a fraction of self-pay prices in the USA, UK, Australia and other high-cost markets (see the cost sections later in this guide, and compare like with like).
• Cancer and neuroscience centres. Major hospitals combine radiation oncology, medical physics, neurosurgery, surgical and medical oncology, radiology and pathology.
• Outpatient treatment. Most courses are delivered as outpatient sessions over days, not weeks, which keeps hospital charges and stay length lower than for open surgery.
• Brain and body applications. Because CyberKnife can treat selected spine, lung, liver, pancreas and prostate targets as well as brain lesions, a single centre can sometimes manage more than one site.
• Access to alternatives. The same hospital can often offer surgery, conventional radiotherapy, Gamma Knife or other LINAC options if CyberKnife turns out not to be the best choice.
• Timely access for planned treatment. Patients whose home system has long waits for stereotactic radiation can often be scheduled once medically cleared.
• International patient support and English-speaking teams. Major hospitals typically help with appointments, hospital letters for visas, airport pick-up, interpreters where needed and accommodation guidance.
• One planned journey. A good programme combines remote case review, planning, treatment and a clear follow-up plan for after you go home.

How Does India Compare with Other Medical Travel Destinations?

Many patients also look at other popular medical-travel destinations before deciding. There is no single best country for every patient; the right choice depends on where you live, your diagnosis and what you can verify about the team and centre. These are the factors worth comparing:

Swipe to see the full table

What Is CyberKnife?

CyberKnife is a dedicated stereotactic radiation platform. It combines a robotic treatment arm with image guidance and computerized planning so beams can approach a target from many directions. The cumulative radiation dose is concentrated within the target while dose falls away outside it.

Is CyberKnife Really Surgery?

No incision is made and no tissue is removed. The term 'radiosurgery' describes the precision and ablative intent of the radiation, not an operation with a scalpel. Patients should distinguish CyberKnife radiosurgery from neurosurgical or cancer surgery because the objectives, risks and recovery are different.

How CyberKnife Works for International Patients in India

CT-based treatment planning defines the target and nearby organs at risk. MRI or PET may be fused when useful. The planning system calculates beam directions and doses; image guidance verifies positioning during delivery. For selected moving body targets, tracking strategies may account for respiratory or target motion.

CyberKnife SRS, SRT and SBRT for International Patients in India

SRS generally refers to highly focused intracranial treatment delivered in one or a few fractions. Fractionated stereotactic radiotherapy divides the dose across several sessions. SBRT applies stereotactic principles to extracranial body targets. The terminology can overlap between centres, so the prescription and number of fractions are more informative than the label alone.

Why Fractionation Matters

Dividing the dose can reduce the dose delivered to nearby sensitive tissue in selected situations. This can be useful for larger targets or lesions close to critical structures where a single ablative dose would exceed normal-tissue tolerance. Fractionation does not automatically make every large lesion safe; target volume and organ constraints still determine feasibility.

Understanding Your Diagnosis and Treatment Objective

Before focusing on the machine, make sure you understand where you stand:

• What is the diagnosis? Is it confirmed by pathology, or a working diagnosis from imaging? Radiation for a brain metastasis, a lung tumor, a spinal metastasis and a prostate cancer are very different treatments.
• What is the goal? Cure, long-term local control, relief of pain or symptoms, or preparing for other treatment each shapes the plan.
• What are the alternatives? Surgery, conventional radiotherapy, systemic therapy, other stereotactic platforms or observation may all be reasonable for some conditions.
• Is tissue diagnosis needed first? Radiation does not provide a biopsy, so if the diagnosis is uncertain, a biopsy may be needed before treatment.
• Is there any urgency? Because the effect develops over time, rapidly worsening symptoms may need a faster treatment first.

A trustworthy team will tell you when CyberKnife is not the best next step. If someone recommends treatment without having reviewed your scans and pathology, treat that as a warning sign.

CyberKnife vs Gamma Knife for International Patients in India

Both can deliver intracranial stereotactic radiosurgery. Gamma Knife is a dedicated cranial radiosurgery platform using multiple cobalt sources, while CyberKnife uses a robotic LINAC and is frameless. CyberKnife can readily deliver treatment over multiple sessions and can treat extracranial targets. The choice for a brain lesion should depend on dosimetry, clinical indication and centre expertise rather than marketing.

CyberKnife vs Modern LINAC SRS/SBRT

Modern LINAC platforms can also provide high-quality SRS and SBRT. In many cases, excellent plans can be produced on more than one platform. Patients should ask whether the proposed plan meets target coverage and organ-at-risk constraints rather than assuming one machine is always superior.

CyberKnife vs Open Surgery for International Patients in India

Surgery physically removes or biopsies tissue and can rapidly relieve mass effect. CyberKnife treats tissue with radiation and its biological effect develops over time. A large symptomatic tumor causing dangerous pressure may require surgery rather than radiosurgery. Conversely, a small well-defined lesion in a difficult surgical location may be suitable for stereotactic radiation.

CyberKnife vs Conventional Radiotherapy for International Patients in India

Conventional radiotherapy commonly uses smaller daily doses over many sessions and treats larger volumes. CyberKnife stereotactic treatment uses fewer, larger, highly conformal fractions for appropriately selected targets. Some diseases require conventional or broader-field radiation and should not be compressed into an SBRT schedule.

CyberKnife vs Other Treatment Options for International Patients in India

Swipe to see the full table

Who May Be a Candidate?

A candidate generally has a clearly defined target for which a safe stereotactic dose can be delivered while respecting nearby critical structures. Performance status, expected benefit, pathology, previous treatment and alternative options also matter. Suitability must be determined by a radiation oncologist and relevant multidisciplinary specialists.

When CyberKnife May Not Be the Best Choice

Very large targets, diffuse/infiltrative disease, poorly defined margins, severe mass effect, urgent decompression needs or inability to meet normal-tissue constraints can make CyberKnife inappropriate. Some tumors are better treated with surgery, conventional fractionated radiotherapy, systemic therapy or observation.

Does Tumor Size Matter?

Yes, but diameter alone is an incomplete rule. Target volume, shape, edema, location and dose to nearby normal structures matter. Single-fraction intracranial SRS is commonly reserved for relatively small well-defined lesions; multi-fraction stereotactic treatment can sometimes accommodate larger targets. A patient should ask for the target volume in cubic centimeters and the proposed fractionation rather than relying only on centimeters.

Targets Near the Optic Nerves or Chiasm

Radiation-sensitive optic structures impose strict dose constraints. A pituitary, meningioma or skull-base lesion abutting the optic apparatus may not be suitable for a high single-fraction dose. Fractionated stereotactic treatment may be considered in selected cases because it can distribute dose across sessions, but safety remains plan-specific.

Targets Near the Brainstem

The brainstem is another critical structure with limited tolerance to high-dose stereotactic radiation. Dose, treated volume and prior radiotherapy influence risk. Fractionation or another treatment strategy may be preferred when the target closely contacts the brainstem.

Find out whether CyberKnife is right for you before you book anything. Send your actual scans (DICOM), pathology, operative notes and any previous radiation details. You will receive a preliminary opinion on suitability, alternatives, the likely number of fractions, the stay in India and an estimated cost.

Brain Metastases

SRS/SRT is widely used for selected brain metastases. Decision-making depends on lesion number, total intracranial tumor volume, size, symptoms, extracranial disease and systemic treatment options. Large symptomatic metastases may require surgical resection; postoperative cavity SRS may then be considered.

Meningioma

Selected small or residual meningiomas can be controlled with stereotactic radiation, particularly when surgery carries substantial risk or a residual component remains after resection. Observation may still be appropriate for selected stable asymptomatic tumors.

Vestibular Schwannoma / Acoustic Neuroma

Stereotactic radiosurgery is an established option for selected small-to-medium vestibular schwannomas. The objective is usually long-term growth control rather than immediate disappearance. Hearing status, tumor size, brainstem compression, age and symptoms influence the choice between observation, microsurgery and radiosurgery. Bring a recent audiogram if you have one.

Pituitary Adenoma

Stereotactic radiation can be used for selected residual, recurrent or medically refractory pituitary tumors. Hormone normalization can take months or years. The optic apparatus, prior surgery, endocrine status and required dose are central to planning. Send hormone blood tests and visual field results, and plan who will monitor your hormones at home.

Skull-Base Tumors

Selected chordoma, chondrosarcoma, schwannoma, paraganglioma and other skull-base targets may be considered for stereotactic treatment, often as part of multimodality care. Histology and previous surgery/radiation strongly affect the treatment plan.

Glioma and Glioblastoma

CyberKnife is not a universal substitute for surgery and standard chemoradiation in diffuse glioma or glioblastoma. Stereotactic re-irradiation may have a role in carefully selected recurrent disease. The infiltrative biology of glioma means that treating only the visible focus may not address microscopic disease.

AVM and Vascular Malformations

Stereotactic radiosurgery can be used for selected brain AVMs. Obliteration develops gradually, so hemorrhage risk does not disappear immediately after treatment. AVM size, location, angioarchitecture and previous embolization/surgery influence the strategy.

Trigeminal Neuralgia

Stereotactic radiosurgery is one treatment option for selected patients with trigeminal neuralgia, particularly when medication fails or invasive surgery is undesirable. Pain relief may be delayed and facial numbness can occur. Keep taking your pain medicines as prescribed until your doctors advise otherwise.

Spine Tumors

CyberKnife SBRT can treat selected spinal metastases and other spinal targets with steep dose gradients around the spinal cord. Mechanical instability, spinal cord compression or need for tissue diagnosis may require surgery before or instead of SBRT.

Lung Tumors

SBRT is an established treatment approach for selected early-stage lung cancers in medically inoperable patients and for selected oligometastatic targets. Central and ultracentral lesions require special caution because of nearby airways, vessels and other organs.

Liver Tumors

Selected primary or metastatic liver tumors can be treated with SBRT when adequate normal liver can be spared. Motion management and liver function are important. Surgery, ablation, embolization and systemic therapy remain alternatives depending on disease.

Pancreatic Cancer

SBRT may be incorporated into selected pancreatic cancer pathways, but it is not a stand-alone cure for most patients. Systemic therapy and surgical resectability remain central. Nearby stomach and bowel dose can limit the stereotactic prescription.

Prostate Cancer

Stereotactic radiation can deliver an entire prostate treatment course in a small number of fractions for appropriately selected patients. Risk group, prostate size, urinary symptoms, anatomy and use of androgen-deprivation therapy affect planning.

Recurrent Tumors and Re-Irradiation

CyberKnife can sometimes be used to re-treat a previously irradiated area because of its conformality. This requires careful reconstruction of the previous radiation dose and assessment of cumulative normal-tissue tolerance. Re-irradiation is a high-complexity decision and should not be marketed simply as 'safe because CyberKnife is precise.'

Consent, Expectations and Family Involvement

• Informed consent. You should understand the objective, the number of fractions, the expected timeline of response, the main risks, the alternatives and what happens if you decline. Ask for an interpreter if needed.
• Realistic expectations. For most tumors the goal is control, not disappearance, and the effect is gradual.
• Family and decision-making. Bring a trusted person to consultations. If your condition may affect decision-making, discuss in advance who will speak for you.
• Cancer care context. If you are on chemotherapy, immunotherapy or targeted therapy, tell the team the drugs and dates and let your home oncologist know about your plans.

Treatment Planning CT

A planning CT is obtained with immobilization appropriate to the body site. The scan becomes the geometric foundation of the treatment plan. Contrast may be used when clinically appropriate.

MRI and PET Fusion

MRI can improve definition of many brain, spine and soft-tissue targets. PET may help define selected metabolically active tumors. Image fusion must be checked carefully because registration errors can affect target definition.

Immobilization and Frameless Treatment

CyberKnife generally avoids an invasive cranial frame. Masks, body supports and other immobilization devices help reproduce position. Frameless does not mean positioning is unimportant; precision depends on immobilization plus image guidance.

Fiducials and Tracking

Some extracranial targets may use implanted fiducial markers, while other tracking methods can rely on skeletal anatomy or other imaging strategies depending on the target and system. If fiducials are proposed, ask about the implantation procedure and risks.

Respiratory Motion Tracking

Tumors in organs such as lung or liver can move with breathing. CyberKnife can use motion-tracking strategies in selected cases so the radiation delivery adapts to target motion. Not every patient or lesion uses the same tracking method.

What Happens During Treatment?

The patient lies on the treatment couch while the robotic arm moves through planned positions. Imaging checks alignment and radiation is delivered from many directions. The patient does not feel the radiation. Treatment time may be longer than a conventional radiotherapy fraction.

Swipe to see the full table

How Many Sessions Are Needed?

Many CyberKnife stereotactic courses are delivered in one to five sessions, but some clinical pathways use other schedules. Fraction number depends on target site, size, histology, previous radiation and normal-tissue constraints. The number of fractions should be decided from the plan, not chosen for travel convenience.

Is CyberKnife Painful?

Radiation delivery itself is painless. Discomfort may come from lying still, the immobilization device, the underlying disease or a fiducial procedure if required. Most adults do not need anaesthesia for treatment.

Does the Patient Become Radioactive?

No. External-beam CyberKnife treatment does not make the patient radioactive. Normal contact with family members is generally safe after treatment. This differs from some forms of internal radiation therapy.

Preparing for CyberKnife Before You Travel

Careful preparation helps you arrive in India safer, better organised and with fewer surprises. Ask your treating team for personalised advice; these are the common areas to discuss:

Swipe to see the full table

How Quickly Does CyberKnife Work?

Radiation causes biological damage that develops over time. Tumor control may mean that a lesion stops growing; shrinkage can take months and some benign tumors may remain visible indefinitely. Symptoms caused by mass effect do not necessarily improve immediately.

Expected Local Control

Local-control rates can be high for appropriately selected stereotactic targets, but the number varies substantially by disease, size, dose, prior treatment and follow-up duration. Patients should ask for diagnosis-specific outcome data rather than a single CyberKnife success percentage.

Early Side Effects

Possible early effects include fatigue, headache, nausea, temporary swelling, local discomfort and site-specific symptoms. Steroids may be prescribed for selected brain cases. Many patients continue normal light activities during an uncomplicated outpatient course.

Radiation Edema

High-dose focal radiation can cause temporary inflammatory swelling. In the brain this may produce headache, weakness, seizures or other neurological symptoms depending on location. Steroids and clinical monitoring may be required.

Radiation Necrosis

Radiation necrosis is delayed injury to treated or adjacent tissue and can occur months or years after stereotactic radiation. Risk depends on dose, volume, location, prior radiation and other factors. Imaging can sometimes have difficulty distinguishing necrosis from tumor progression.

Other Late Effects

Late risks are site-specific and can include cranial nerve injury, endocrine dysfunction, cognitive effects, fracture, organ injury or vascular effects. The probability depends on the target and dose to nearby tissues. A high-quality plan explicitly documents organ-at-risk constraints.

CyberKnife After Previous Surgery for International Patients in India

CyberKnife is commonly considered for residual or recurrent disease after surgery when a defined target remains. Postoperative imaging and pathology guide the decision. Timing depends on wound recovery, diagnosis and whether other therapy is required.

CyberKnife Before Surgery

In some body-tumor pathways radiation may be delivered before surgery, but this is diagnosis-specific and not a routine rule for CyberKnife. Multidisciplinary sequencing matters more than the platform name.

CyberKnife With Chemotherapy or Immunotherapy for International Patients in India

Systemic treatment may be given before, during or after stereotactic radiation depending on cancer type. Drug-radiation interactions and toxicity must be reviewed by the oncology team. Patients should not independently stop or continue anticancer medicines around treatment.

Multidisciplinary Review

Complex cases benefit from review by radiation oncology plus the relevant neurosurgical, surgical, medical-oncology, radiology and pathology teams. This is especially important when both surgery and stereotactic radiation are reasonable options.

Steroids and Other Medicines During Treatment

• Steroids. If prescribed to reduce swelling, follow the dose and taper exactly and do not stop suddenly. They can raise blood sugar, upset the stomach and disturb sleep or mood.
• Anti-seizure medicines. Continue as prescribed and never stop abruptly.
• Anticancer medicines. Do not stop or restart them unless your oncologist advises.
• Blood thinners. Restart only when your team says it is safe, especially if fiducials or brain lesions are involved.

Choosing a CyberKnife Centre in India

Look beyond ownership of the machine. Ask about radiation-oncology experience with the exact diagnosis, medical-physics support, quality assurance, imaging integration, emergency support and access to surgery if complications or decompression are needed. For brain cases, integration with neurosurgery and neuroradiology is particularly valuable.

Choosing the Treating Specialist

Ask how frequently the radiation oncologist treats the specific tumor and whether the case will be peer-reviewed or discussed in a tumor board. Treatment planning expertise is as important as the hardware.

Major Treatment Hubs for International Patients in India

CyberKnife and advanced stereotactic radiation services are concentrated in major tertiary centres, including Delhi NCR and other metropolitan oncology hubs. Availability changes over time. International patients should verify that the exact platform and required tracking/planning capability are currently operational before travel.

CyberKnife Cost in India for International Patients

Published 2026 prices are inconsistent because some sources quote a simple stereotactic course while others quote complex international packages. A practical planning range for many international patients is approximately US$6,000-12,000 for a straightforward course, while complex multi-fraction, re-irradiation, fiducial, extensive imaging or bundled pathways can be higher and some published estimates extend well beyond US$20,000. The final quotation should specify diagnosis, fractions, imaging, tracking method and whether specialist consultations and follow-up are included.

Why CyberKnife Prices Vary

Cost is influenced by target site, number of fractions, planning complexity, previous radiation, MRI/PET fusion, fiducial implantation, motion tracking, anaesthesia/sedation, hospitalization, physician fees and whether the quote includes international-patient services. A low headline price should not be compared with an all-inclusive package without itemizing both.

What the Package Should Include

Ask for radiation-oncology consultation, simulation CT, immobilization, treatment planning, medical-physics dosimetry, image fusion where required, all prescribed CyberKnife fractions, routine on-treatment review and initial follow-up. Clarify whether MRI/PET, fiducials, anaesthesia, hospital admission, pathology, systemic therapy, medicines and treatment of complications are excluded.

Cost in India vs Other Countries

India can offer a substantial self-pay cost advantage, but published international CyberKnife prices are less standardized than surgical package prices. Therefore, the comparison should be treated as planning guidance rather than a guaranteed tariff. The most meaningful comparison is the total cost for the same diagnosis, same number of fractions and equivalent planning/imaging requirements.

CyberKnife Treatment Cost - India vs Other Countries

Swipe to see the full table

*Savings are approximate planning comparisons, not fixed tariffs. Published prices vary substantially by diagnosis, fractions, imaging, previous radiation and package definition. Obtain itemized quotations before making a travel decision.

Budgeting for the Whole Journey

Swipe to see the full table

Quotation Comparison Table

Swipe to see the full table

A cheaper quotation may exclude imaging, fiducials, physics or follow-up that are part of the other plan. Compare clinical content before price.

Warning Signs of an Unreliable Offer

Medical travel works best when the information you receive is specific, itemized and clinically sensible. Be cautious if you see any of the following:

What a Good International Patient Service Should Provide

A well-run programme should make the journey easier at every stage:

• A named coordinator and a direct line to the clinical team before you travel
• Review of your actual DICOM imaging, pathology and previous radiation records by the appropriate specialists, and a written preliminary opinion
• Honest discussion of alternatives, including surgery, other radiation platforms and observation
• Multidisciplinary review for complex cases
• An itemized written estimate that states inclusions and exclusions
• A hospital letter for your medical visa application, and guidance for attendant visas
• Airport pick-up and help with nearby accommodation
• Interpreter support where needed, and support for families, including paediatric patients
• A clear treatment summary with dose and fraction details, medicines and an imaging schedule
• A defined follow-up pathway after you return home

Remote Case Review Before Travel

Send DICOM imaging, pathology, prior treatment records and previous radiation plans if any. A preliminary review should answer whether CyberKnife is technically plausible, what further imaging is required, the likely number of fractions and whether another modality may be better. Re-irradiation cases should send the original radiotherapy dose plan whenever available.

Medical Records to Send

Provide current CT/MRI/PET as relevant, pathology, operative notes, radiotherapy summary and DICOM dose files, systemic-treatment history, laboratory results and current medicines. For brain lesions include neurological symptoms, seizure history and steroid use.

Step-by-Step International Patient Journey

1) Send imaging and medical records. 2) Obtain radiation-oncology review. 3) Confirm CyberKnife versus alternatives. 4) Receive provisional fractionation and quotation. 5) Arrange visa and travel. 6) Complete in-person evaluation and planning imaging. 7) Undergo simulation and treatment planning. 8) Receive prescribed fractions. 9) Complete treatment review. 10) Return home with a surveillance plan. The planning stage can take longer than the radiation-delivery days themselves.

How Long to Stay for International Patients in India

For an uncomplicated short CyberKnife course, many international patients can plan roughly 7-14 days in India, allowing time for consultation, imaging, planning, treatment and review. Complex re-irradiation or combined treatment may require longer. Do not book inflexible flights before the treating team confirms the planning schedule.

Flying After CyberKnife

Most uncomplicated outpatient patients do not face the same post-craniotomy flying restrictions as open neurosurgery. However, neurological symptoms, edema, seizures, steroid needs or the underlying cancer can affect fitness to fly. Obtain individualized clearance for symptomatic brain disease or medically complex patients.

Accommodation and Attendant

Hotel or serviced accommodation near the treatment centre is usually adequate for stable outpatients. An attendant is helpful for older patients, neurologically symptomatic patients or those undergoing treatment away from home. Patients with significant weakness, seizures or cognitive problems should not travel alone.

Medical Visa and Documentation

Use the appropriate Indian medical-visa route and verify current nationality-specific requirements through official channels. Carry the hospital invitation, treatment plan and relevant medical documents. Rules can change, so visa eligibility should be confirmed before non-refundable bookings.

Airline and Travel Practicalities After CyberKnife

The flight home is part of your recovery. A little planning can make it safer and more comfortable.

Swipe to see the full table

Follow-Up After Returning Home

Follow-up is diagnosis-specific and usually includes clinical review and interval imaging. Early scans can show swelling or treatment-related change and should not automatically be interpreted as treatment failure. Share follow-up imaging with both the treating centre and a local specialist.

Arranging Your Follow-Up Care at Home Before You Leave

One of the most common worries for international patients is: 'Who will look after me when I am back home?' The answer should be settled before you travel to India, not after you return. A local specialist may be reluctant to take responsibility for treatment performed elsewhere, so it is wise to arrange routine support early and keep the Indian team involved for treatment-specific questions.

Swipe to see the full table

Before You Leave India, Make Sure You Have

• A treatment summary including diagnosis, target(s), total and per-fraction dose, number of fractions and platform
• The treatment plan and dose files on disc or in digital form, which are essential if you ever need further radiation
• The planning scans in DICOM form
• A written medicine list including steroids, anti-seizure medicines and cancer medicines
• Information about any fiducial markers left in place
• A follow-up imaging schedule and any other tests needed
• The contact details of the Indian team and an agreed way to send scans and reports
• A short emergency summary letter for a local emergency department stating your diagnosis, treatment, medicines and allergies

When to Seek Urgent Care

Do not wait for an overseas teleconsultation when emergency neurological or oncological symptoms occur.

Twenty Questions to Ask the CyberKnife Team

1. What is my exact diagnosis and treatment objective?
2. Why is CyberKnife appropriate for me?
3. What are the alternatives?
4. Would Gamma Knife or another LINAC give an equivalent plan?
5. Do I need surgery or biopsy first?
6. What is my target size and volume?
7. How close is the target to critical structures?
8. How many fractions do you recommend and why?
9. What total and per-fraction dose is planned?
10. Do I need MRI or PET fusion?
11. Will fiducials be required?
12. How will target motion be tracked?
13. Have I had previous radiation that changes the plan?
14. What local-control rate is expected for my diagnosis?
15. What are my specific early and late risks?
16. What is the risk of radiation necrosis?
17. What exactly is included in the quotation?
18. How many days should I stay in India?
19. When can I fly home?
20. What imaging and follow-up schedule will I need?

Who Is a Good Candidate for Medical Travel for CyberKnife?

A reasonable candidate is medically stable enough to travel, has a well-defined target that can be reviewed before departure, has time to complete planning and treatment, and has a clear follow-up pathway at home. The expected benefit of travelling should exceed the inconvenience and cost of international care.

Who Should Think Carefully Before Travelling?

Patients with neurological emergencies, severe mass effect, uncontrolled seizures, rapidly worsening symptoms, unstable systemic illness or an immediate need for decompressive surgery should not delay urgent local care simply to travel for CyberKnife. Travel may also be unnecessary when an equivalent high-quality stereotactic treatment is readily available locally.

Frequently Asked Questions on CyberKnife Treatment for International Patients in India

CyberKnife Treatment Checklist for International Patients in India

Sources

1. 1. American Association of Neurological Surgeons (AANS) - Stereotactic Radiosurgery: https://www.aans.org/patients/conditions-treatments/stereotactic-radiosurgery/
2. 2. International Stereotactic Radiosurgery Society (ISRS) - Guidelines summaries: https://www.guidelinecentral.com/guidelines/isrs
3. 3. Government of India - Indian Visa Online (e-Medical Visa and e-Medical Attendant Visa): https://indianvisaonline.gov.in/evisa/